About Quantapore
Quantapore is a biotech company developing nanopore-based nucleic acid sequencing technology using an optical readout approach. Its proprietary platform uses an optically labeled nanopore that interacts via energy transfer with labeled DNA strands, enabling single-molecule sequencing at high throughput and low cost. The company serves researchers in genomics and proteomics seeking advanced single-molecule analytical tools.
Company details
Funding
Total raised
$50.5M
Last stage
Series C
Investors
Founders
Martin Huber
Ph.D. in Genetics and Biochemistry from the University of Vienna. Over 20 years of experience in biotech startups in Europe and the US. Served as founder, CTO, and ultimately CEO of Quantapore. Previously held senior scientist positions at Ion Torrent and Nanosphere. Later joined Nautilus Biotechnology as VP of Biochemistry and Flow Cell Development.
Sascha C. Dennstedt
Co-founder of Quantapore and founder of at least one other company.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.